| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $31K | -77.2% | -98.4% |
| SG&A Expense | $1.5M | -10.2% | +2.9% |
| Operating Income | -$8.4M | -7.3% | +4.9% |
| Net Income | -$9.4M | -42.3% | -41.3% |
| EPS (Basic) | -$0.42 | -27.3% | +8.3% |
| EPS (Diluted) | -$0.42 | -27.3% | +8.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $88.2M | +5.7% | +243.9% |
| Current Assets | $118.1M | +11.0% | +211.2% |
| Total Assets | $672.1M | +11.9% | +76.2% |
| Current Liabilities | $59.1M | +11.6% | +71.9% |
| Long-term Debt | $44.6M | +36.8% | — |
| Total Liabilities | $125.5M | +14.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$27.0M | — | — |
| Investing Cash Flow | -$112.8M | — | — |
| Financing Cash Flow | $194.0M | — | — |
| +123.3% |
| Stockholders' Equity | $395.6M | +10.2% | +64.9% |